Functional gastrointestinal disorders such as functional dyspepsia and irritable bowel syndrome are very common and show considerable alterations in gut-brain signaling. This has recently be extended by the gut microbiome and therefore also referred as microbiome-gut-brain axis. The importance of these alterations has been taken into consideration in the new Rome IV criteria summarizing the disorders of the gut-brain interaction. The present Research Topic will highlight new developments :- in the pathophysiology of functional gastrointestinal disorders such as inflammatory and microbiotic changes- in the – still challenging – treatment of these conditions. We are calling authors to submit the latest…
Author: Praveen Suthrum
After an excellent debate on the future of telemedicine in GI in our most recent Perspectives column, we continue to explore changes in the way we traditionally provide care. In this issue, we discuss the GI hospitalist service, a relatively new but growing model of providing inpatient care. Is this the new ideal, allowing for more efficient care? Or are traditional or alternative models more appropriate? As with most things, the answer often lies somewhere in the middle, driven by local needs and infrastructure. Dr. Tau and Dr. Mehendiratta explore the pros and cons of these different approaches to providing…
Background and Aims Functional gastrointestinal disorders are common and costly to the healthcare system. In the MANTRA study, we demonstrated that multidisciplinary care resulted in superior clinical and cost outcomes, when compared with standard gastroenterologist-only care at end of treatment. In this study we evaluate the longer-term outcomes.
Artificial intelligence (AI) has arrived and it will directly impact how we assess, monitor, and manage inflammatory bowel disease (IBD). Advances in the machine learning methodologies that power AI have produced astounding results for replicating expert judgment and predicting clinical outcomes, particularly in the analysis of imaging. This review will cover general concepts for AI in IBD, with descriptions of common machine learning methods, including decision trees and neural networks. Applications of AI in IBD will cover recent achievements in endoscopic image interpretation and scoring, new capabilities for cross-sectional image analysis, natural language processing for automated understanding of clinical text,…
CARLSBAD, Calif., January 5, 2022 (Newswire.com) – Virgo Surgical Video Solutions, the leading cloud video and artificial intelligence platform for endoscopic medicine, announced the closing of its Series A financing — led by FCA Venture Partners and including participation from Tom Williams of Heron Rock Fund, who led Virgo’s seed round — to scale its proprietary solutions for accelerating clinical trials. Virgo is widely regarded as the industry leader for capturing and managing endoscopic video data, and the company provides a unique set of tools, called VirgoTrials, which help healthcare providers leverage this data for clinical trial recruitment.
Younger and older patients with metastatic colorectal cancer had similar survival outcomes despite differences in fitness levels and treatment intensity, according to study results published in Journal of the National Cancer Institute. The lack of a significant survival benefit in the CALGB/SWOG 80405 trial for those with young-onset disease — who typically have more favorable characteristics such as left-sided tumors and receive higher doses of chemotherapy — may be due to diagnosis at more advanced stages, differences in underlying tumor biology or other, unidentified factors increasing disease aggression, researchers wrote.
DALLAS, Jan. 6, 2022 /PRNewswire/ — GI Alliance, the nation’s largest independent gastroenterology services organization, is excited to announce its partnership with Digestive Disease Consultants, the leading provider of independent GI services providing quality care to patients in the Normal and Bloomington areas of Illinois. This expansion complements GI Alliance’s presence as the leading provider of independent GI care in the state and the Midwest.
U.S. Digestive Health, a network of top-rated gastrointestinal (GI) practices managed by US Digestive Health Management, a management services organization created to expand access to high-quality, low-cost gastroenterology care, announced today that it has partnered with Gastrointestinal Specialists (“GI Specialists”), a leading gastroenterology practice based in Northeast Philadelphia. With the addition of this new partnership, U.S. Digestive Health Management now oversees a network of gastroenterology providers and services with 24 locations, 13 ambulatory surgery centers, 101 physicians, 43 advanced practice providers, and more than 700 total employees.
Miami-based Gastro Health is starting off the new year with two major deals in Maryland and Florida, according to two Jan. 5 news releases shared with Becker’s ASC Review. The fast-growing, private equity-backed company has a presence in Florida, Alabama, Washington, Virginia, Ohio and Maryland with over 140 locations and 315 physicians.
WaGI is the largest independent gastroenterology (GI) practice in Washington and is one of the largest independent GI practices in the country. With nearly five decades of providing care to patients, the WaGI clinical team consists of 31 board-certified gastroenterologists and 17 advanced practice providers. They deliver care across 17 strategically located offices, seven dedicated GI ambulatory surgery centers, and three infusion centers.